Asa Elmore | Sutro Biopharma, Inc.

Sutro Biopharma to Present at the Cowen 43rd Annual Health Care Conference

Events, News, Presentations, Press Releases

Sutro Biopharma to Present at the Cowen 43rd Annual Health Care Conference SOUTH SAN FRANCISCO, Calif., March 1, 2023 – Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody...

Sutro Biopharma Appoints Dr. Anne Borgman as Chief Medical Officer

News, Press Releases

Sutro Biopharma Appoints Dr. Anne Borgman as Chief Medical Officer SOUTH SAN FRANCISCO, Calif., February 28, 2023 – Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug...

Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

News, Press Releases

Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SOUTH SAN FRANCISCO, Calif., February 17, 2023 – Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format...

BioNova Announces First Patient Dosed in a Phase 1/2 Study of BN301 for the Treatment of Hematologic Malignancies in China

News

BioNova Announces First Patient Dosed in a Phase 1/2 Study of BN301 for the Treatment of Hematologic Malignancies in China Download SHANGHAI, China, February. 9, 2023 – BioNova Pharmaceuticals Limited (BioNova), a company dedicated to the discovery, development...

Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha, for the Treatment of Ovarian and Endometrial Cancers – Molecular Cancer Therapeutics – AACR Journals

Presentations

Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha, for the Treatment of Ovarian and Endometrial Cancers – Molecular Cancer Therapeutics – AACR Journals...

« Older Entries

Next Entries »